SCHEMBL19204871

SCHEMBL19204871

NC(=O)c1nc(Cl)c(Cl)cc1F

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC9A1 P19634 3/20 0.41
LMNA P02545 3/20 0.39
KEAP1 Q14145 1/20 0.39
NFE2L2 Q16236 1/20 0.39
CASP1 P29466 2/20 0.39
POLB P06746 1/20 0.38
KDM4E B2RXH2 3/20 0.36
ALDH1A1 P00352 3/20 0.36
GLA P06280 3/20 0.36
HPGD P15428 3/20 0.36
HSD17B10 Q99714 3/20 0.36
GAA P10253 2/20 0.36
PLAU P00749 2/20 0.36
CYP1A2 P05177 2/20 0.36
SLC22A1 O15245 1/20 0.36
HTR1A P08908 1/20 0.36
CYP2D6 P10635 1/20 0.36
TSHR P16473 1/20 0.36
MAOA P21397 1/20 0.36
ADORA2A P29274 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7587086 0.82 KEAP1 (0.48) SLC9A1LMNAKEAP1NFE2L2ALDH1A1
SCHEMBL24222874 0.81 POLB (0.47) SLC9A1LMNAKEAP1NFE2L2CASP1
SCHEMBL28043598 0.77 NPSR1 (0.45) KDM4EALDH1A1HSD17B10GAA
SCHEMBL15651124 0.71 IKBKB (0.40) LMNACASP1ALDH1A1GAAIDO1
SCHEMBL566114 0.69 CASP1 (0.47) SLC9A1LMNAKEAP1NFE2L2CASP1
SCHEMBL29406095 0.69 CASP1 (0.47) SLC9A1LMNAKEAP1NFE2L2CASP1
SCHEMBL6222738 0.69 KEAP1 (0.50) KEAP1NFE2L2TDP1
SCHEMBL7910786 0.69 BACE1 (0.39) CASP1PLAUIDO1GRM2
SCHEMBL18340314 0.69 LMNA (0.39) LMNAPOLBALDH1A1GAA
SCHEMBL21543008 0.69 LMNA (0.39) SLC9A1LMNACASP1POLBKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017133664-A1 BICYCLIC PYRIDINE AND PYRIMIDINE DERIVATIVES AND THEIR USE IN THE TREATMENT, AMELIORATION OR PREVENTION OF INFLUENZA SAVIRA PHARMACEUTICALS GMBH (AT) 2017-08-10 WO disclosed
WO-2017133667-A1 PYRIMIDINE AND PYRIDINE DERIVATIVES AND USE IN TREATMENT, AMELIORATION OR PREVENTION OF INFLUENZA THEREOF SAVIRA PHARMACEUTICALS GMBH (AT) 2017-08-10 WO disclosed